Form 4: Clover Health Executive Brady Priest Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Brady Priest, CEO of Home Care at Clover Health, disposed of 32,416 shares of Class A Common Stock on July 18, 2024, to cover tax obligations related to vesting restricted stock units.
Summary
- On July 18, 2024, Brady Priest, CEO of Home Care at Clover Health Investments, Corp., disposed of 32,416 shares of Class A Common Stock.
- The shares were withheld to cover tax obligations upon the vesting of 6.25% of time-based restricted stock units (RSUs) granted on July 18, 2022.
- The transaction occurred at a price of $1.69 per share.
- Following the transaction, Priest directly owns 1,866,199 shares of Class A Common Stock.
- The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date on July 18, 2026, contingent upon continued service.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations and vesting schedules. It doesn't indicate positive or negative sentiment towards the company's future prospects.
Future Outlook
The remaining RSUs will continue to vest quarterly until July 18, 2026, subject to Brady Priest's continued service with Clover Health.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the executive's confidence in the company.
Comparison to Industry Standards
- Similar transactions are common among executives at publicly traded companies like UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS), where stock-based compensation is a significant part of their overall remuneration.
- Executives often sell shares to cover tax liabilities arising from the vesting of restricted stock units or the exercise of stock options.
- The amount of shares disposed of is relatively small compared to the total holdings, suggesting it's primarily for tax purposes rather than a strategic divestment.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, as it is a routine disposal of shares for tax purposes.
- Employees may see this as a standard part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 07/18/2022 | Original grant date of time-based restricted stock units (RSUs). |
| 07/18/2024 | Date of transaction: Disposal of shares to cover tax obligations upon vesting of RSUs. |
| 07/18/2026 | Final vesting date of the remaining RSUs, contingent upon continued service. |
| 07/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.